Related Experiment Video
Updated: Mar 29, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Treatment of Neuroendocrine Liver Metastases
Heather A Farley1, Rodney F Pommier1
1Division of Surgical Oncology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Mail Code L 619, Portland, OR 97329, USA.
Abstract:
Neuroendocrine tumors are rare and slow-growing malignancies that commonly metastasize to the liver, resulting hormonal syndromes and death from liver failure. Surgical consultation and liver debulking are key components in management. Traditional surgical resection guidelines do not apply to these tumors as with other cancers. Surgical resection has shown survival benefit even in the event of an incomplete resection. Ablation may be used as an adjunct to resection or in patients who are not candidates for resection. Asymptomatic patients with high-volume disease do as well with intra-arterial therapy as with surgery.

